24 May 2013
Keywords: array, bio, adjusts, growth, expectations, firm, biopharma
Article | 06 January 2003
US firm Array BioPharma is revising its revenue forecast for the fiscalyear ending June 30, 2003, and is now forecasting an annual ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.